[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[e-drug] updated HIV-drug pricelist


  • Subject: [e-drug] updated HIV-drug pricelist
  • From: e-drug@usa.healthnet.org
  • Date: Tue, 5 Jun 2001 06:24:17 -0400 (EDT)

E-DRUG: updated HIV-drug pricelist
---------------------------------------------------
[From the UNICEF Supply website: http://www.supply.unicef.dk/
]

Of the more than 36 million people living with HIV/AIDS today, over 95% live in 
developing countries. Many of them do noy have access to even the basic 
drugs needed to treat HIV-related infections and other conditions. In many of 
the poorest countries, essential drugs including painkillers, antibiotics, and 
tuberculosis drugs are in desperately short supply. The high price of many 
AIDS drugs � especially antiretroviral drugs � is one of the main barriers to their 
availability in developing countries. However, even where cheaper alternatives 
exist, many decision-makers do not have the information they need to identify 
manufacturers which can supply these drugs. They require easier access to 
comparative prices. This report sets out to provide that data -- market 
information that can be used to help government procurement agencies make 
informed decisions on the source of drugs and serve as the basis for 
negotiating affordable prices. The aim is to help increase access to drugs for 
people in developing countries living with HIV/AIDS. The report is based on a 
survey of over 200 pharmaceutical manufacturers in 40 countries world wide. It 
is the latest in a series of reports launched in 2000 and issued twice a year by 
UNICEF, UNAIDS, WHO and MSF.  

The full (36-page) report is downloadable as a PDF file from:
http://www.supply.unicef.dk/insideSD/HIVMay2001.pdf

[WB]

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.